---
audienceLevel: patient
cancerTypes:
- liver
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Drugs Approved for Liver Cancer - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/liver
version: v1
---

# Drugs Approved for Liver Cancer - NCI

# Drugs Approved for Liver Cancer

This page lists cancer drugs approved by the Food and Drug Administration (FDA) for liver cancer. The list includes generic names and brand names. The drug names link to NCIâ€™s Cancer Drug Information summaries. There may be drugs used in liver cancer that are not listed here.

## Drugs Approved for Liver Cancer

- [Atezolizumab](/about-cancer/treatment/drugs/atezolizumab)
- [Atezolizumab and Hyaluronidase-tqjs](/about-cancer/treatment/drugs/atezolizumab-and-hyaluronidase-tqjs)
- [Avastin (Bevacizumab)](/about-cancer/treatment/drugs/bevacizumab)
- [Bevacizumab](/about-cancer/treatment/drugs/bevacizumab)
- [Cabometyx (Cabozantinib-S-Malate)](/about-cancer/treatment/drugs/cabozantinib-s-malate)
- [Cabozantinib-S-Malate](/about-cancer/treatment/drugs/cabozantinib-s-malate)
- [Cyramza (Ramucirumab)](/about-cancer/treatment/drugs/ramucirumab)
- [Durvalumab](/about-cancer/treatment/drugs/durvalumab)
- [Futibatinib](/about-cancer/treatment/drugs/futibatinib)
- [Imfinzi (Durvalumab)](/about-cancer/treatment/drugs/durvalumab)
- [Imjudo (Tremelimumab-actl)](/about-cancer/treatment/drugs/tremelimumab-actl)
- [Ipilimumab](/about-cancer/treatment/drugs/ipilimumab)
- [Keytruda (Pembrolizumab)](/about-cancer/treatment/drugs/pembrolizumab)
- [Lenvatinib Mesylate](/about-cancer/treatment/drugs/lenvatinibmesylate)
- [Lenvima (Lenvatinib Mesylate)](/about-cancer/treatment/drugs/lenvatinibmesylate)
- [Lytgobi (Futibatinib)](/about-cancer/treatment/drugs/futibatinib)
- [Nexavar (Sorafenib Tosylate)](/about-cancer/treatment/drugs/sorafenibtosylate)
- [Nivolumab](/about-cancer/treatment/drugs/nivolumab)
- [Nivolumab and Hyaluronidase-nvhy](/about-cancer/treatment/drugs/nivolumab-and-hyaluronidase-nvhy)
- [Opdivo (Nivolumab)](/about-cancer/treatment/drugs/nivolumab)
- [Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)](/about-cancer/treatment/drugs/nivolumab-and-hyaluronidase-nvhy)
- [Pemazyre (Pemigatinib)](/about-cancer/treatment/drugs/pemigatinib)
- [Pembrolizumab](/about-cancer/treatment/drugs/pembrolizumab)
- [Pemigatinib](/about-cancer/treatment/drugs/pemigatinib)
- [Ramucirumab](/about-cancer/treatment/drugs/ramucirumab)
- [Regorafenib](/about-cancer/treatment/drugs/regorafenib)
- [Sorafenib Tosylate](/about-cancer/treatment/drugs/sorafenibtosylate)
- [Stivarga (Regorafenib)](/about-cancer/treatment/drugs/regorafenib)
- [Tecentriq (Atezolizumab)](/about-cancer/treatment/drugs/atezolizumab)
- [Tecentriq Hybreza (Atezolizumab and Hyaluronidase-tqjs)](/about-cancer/treatment/drugs/atezolizumab-and-hyaluronidase-tqjs)
- [Tremelimumab-actl](/about-cancer/treatment/drugs/tremelimumab-actl)
- [Yervoy (Ipilimumab)](/about-cancer/treatment/drugs/ipilimumab)
